Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
Open Access
- 27 February 2023
- journal article
- research article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (4) , 871-874
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- SCID newborn screening: What we’ve learnedJournal of Allergy and Clinical Immunology, 2021
- Establishing Simultaneous T Cell Receptor Excision Circles (TREC) and K-Deleting Recombination Excision Circles (KREC) Quantification Assays and Laboratory Reference Intervals in Healthy Individuals of Different Age Groups in Hong KongFrontiers in Immunology, 2020
- Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined ImmunodeficiencyFrontiers in Immunology, 2020
- A novel pathogenic mutation on Interleukin-7 receptor leading to severe combined immunodeficiency identified with newborn screening and whole exome sequencingJournal of Microbiology, Immunology and Infection, 2020
- Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal StrategiesJournal of Crohn's and Colitis, 2018
- Newborn Screening for SCID in New York State: Experience from the First Two YearsJournal of Clinical Immunology, 2014
- Severe Viral Infections and Primary ImmunodeficienciesClinical Infectious Diseases, 2011
- Lymphocyte Subsets in Cord Blood of Preterm Infants: Effect of Antenatal SteroidsNeonatology, 1998